Summarize this paper and general a comparison table based on this framework: Definition Prevalence Causes Classification Risk factors Complications Management Prognosis

I can only give a limited summary from the provided sources because the available evidence does not clearly identify the full paper content. The relevant source describes a paper about pericardial effusion (PE) in COVID-19, focused on prevalence, risk factors, prognosis, late outcomes, and management .

What the available evidence supports

• The paper appears to investigate PE in COVID-19, including prevalence, risk factors, prognosis, late clinical outcomes, and management .
• The study classified 256 patients with PE by effusion size as mild, moderate, or large .
• Mean age increased across PE severity groups: mild 62.17 ± 16.34 years, moderate 69.12 ± 12.52 years, and large 72.44 ± 15.26 years .
• Insufficient evidence is available from the provided sources to reliably summarize the full methods, results, conclusions, or detailed clinical recommendations.

Comparison table based on your framework

Framework item	Summary from available evidence
Definition	PE appears to refer to pericardial effusion in the context of COVID-19, but the provided evidence does not include the paper’s exact definition .